OXL 001
Alternative Names: LipAprep; OXL-001Latest Information Update: 11 Jan 2023
At a glance
- Originator Oxilio
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Cancer